Department of Health Systems, Management and Policy and the Associate Dean, Colorado School of Public Health, University of Colorado, Aurora, CO, USA.
Department of Health Behavior and Policy, Virginia Commonwealth University, Richmond, VA, USA.
Soc Sci Med. 2020 Nov;265:113515. doi: 10.1016/j.socscimed.2020.113515. Epub 2020 Nov 10.
We explore whether a cash incentive to see a primary care provider (PCP) improves self-reported depression, anxiety, and pain among low-income patients in a randomized trial.
Secondary outcomes of a randomized controlled trial, enrolling low-income uninsured adults to receive cash incentives ($0, $25, $50) to see a PCP.
Interview data was collected at enrollment and 12 months later. Health outcomes were measured with the PROMIS depression, anxiety, and pain interference scales. We estimated adjusted logistic regressions to determine whether self-reported improvements occurred in depression, anxiety, or pain.
981 subjects completed surveys 12 months following study enrollment (80% retention). Subjects who were incentivized were 5.7 percentage points more likely to see a PCP in the initial six months (p<0.05). Incentivized subjects were 6 percentage points more likely to experience an improvement in depression and pain at 12 months. Among those who reported high levels of depression and pain at baseline, they were 10.6 and 8 percentage points, respectively, to experience an improvement relative to those who were not incentivized.
Meaningful improvements were observed for depression and pain PROMIS domains for subjects randomized to the incentive groups, presumably through their interaction with a PCP and the health care system. This finding was robust for the full sample and a group that reported more severe symptoms at baseline.
我们通过一项随机试验,探讨向初级保健提供者(PCP)就诊的现金激励是否能改善低收入患者的自我报告的抑郁、焦虑和疼痛。
这是一项随机对照试验的次要结果,招募低收入无保险的成年人,给予现金激励(0 美元、25 美元、50 美元)以看 PCP。
在入组时和 12 个月后收集访谈数据。使用 PROMIS 抑郁、焦虑和疼痛干扰量表来衡量健康结果。我们估计了调整后的逻辑回归,以确定自我报告的抑郁、焦虑或疼痛是否有所改善。
981 名受试者在研究入组后 12 个月完成了调查(保留率为 80%)。在最初的 6 个月内,接受激励的受试者看 PCP 的可能性增加了 5.7 个百分点(p<0.05)。激励组在 12 个月时抑郁和疼痛的改善可能性增加了 6 个百分点。在基线时报告有较高水平抑郁和疼痛的受试者中,与未接受激励的受试者相比,他们分别有 10.6 和 8 个百分点的可能性改善。
激励组的受试者在抑郁和疼痛 PROMIS 领域观察到了有意义的改善,这可能是通过他们与 PCP 和医疗保健系统的互动产生的。这一发现对全样本和基线时报告症状更严重的组都是稳健的。